Summary
• United States Antimony Corporation (UAMY) experienced a 3.8% rise in pre-market trading, reflecting increasing investor interest, without significant new news.
• The company reported a 182% year-over-year revenue increase for Q3 2025, alongside a $106.7 million supply agreement for antimony trioxide, indicating strong market positioning.
• Analyst upgrades, including a “Buy” rating from HC Wainwright & Co. with a price target of $8.50 to $10.25, further bolster confidence in UAMY’s growth potential.
United States Antimony Corporation (UAMY) is up 3.8% in pre-market trading, reaching $7.35 compared to its last close of $7.08. This price action indicates a growing interest in the stock, evident from its recent developments, even though there isn’t any fresh significant news driving the move.
Earnings Upgrade Signals Positive Momentum
On November 12, 2025, UAMY reported robust financial results for the third quarter, highlighting a remarkable 182% year-over-year increase in revenues, totaling $26.23 million. Gross profits rose sharply by 219% year-over-year, reflecting strong operational efficiencies and market positioning. While some challenges were noted with EPS, as the actual figure came in at -$0.04 versus an estimate of $0.02, the overall financial performance indicates a trend of significant growth in the critical minerals sector.
Additionally, the company executed a substantial supply agreement with a U.S. industrial customer for antimony trioxide, valued at approximately $106.7 million. This agreement not only ensures consistent demand but also underlines United States Antimony’s pivotal role in the domestic supply chain for critical minerals.
Regulatory Filings and Disclosures
Most recently, on November 14, UAMY filed an 8-K, covering various operational updates and prior financial performance. These filings serve as a platform to maintain transparency with investors during this critical growth phase. The latest report tied to the 2025 third-quarter results was well received and adds another layer of credibility to the company’s upward trajectory.
Market and Technical Picture
UAMY’s market performance has showcased significant volatility, with an average volume of approximately 14.2 million over three months and nearly 10.9 million in the last ten days. The stock has exhibited an impressive year-to-date performance of 370.1%, while the quarterly performance was marked at 119.5%. In the context of technical indicators, the 14-day RSI stands at 43.04, suggesting a relatively neutral market sentiment. With its upcoming trading sessions, traders might keep an eye on the 20-day SMA, which reflects a deviation of -15.7% from current prices, indicating areas where the stock could gain traction.
Analyst Sentiment
Recent analyst upgrades underscore confidence in UAMY’s growth trajectory. HC Wainwright & Co. maintained a “Buy” rating for UAMY on November 13, with a price target ranging between $8.50 and $10.25. This positive sentiment aligns with the company’s strong operational results and potential market opportunities in the critical minerals space.
With shares displaying solid gains in pre-market trading, United States Antimony Corporation continues to attract investor interest, bolstered by performance metrics that suggest a robust fundamental footing in a competitive sector.


